A maior rede de estudos do Brasil

Grátis
13 pág.
Diretrizes - Sindrome Cushing Independente do Hormônio ACTH

Pré-visualização | Página 4 de 4

syndrome
and the nodular adrenal gland. Endocrinol
Metab Clin North Am. 1994;23(3):555-69.
4. Latronico AC, Chrousos GP. Adrenocortical
tumors. J Clin Endocrinol Metab 1997;82:
1317-24.
5. Luton JP, Cerdas S, Billaud L, Thomas G,
Guilhaume B, Bertagna X, et al. Clinical features
of adrenocortical carcinoma, prognostic factors,
and the effect of mitotane therapy. N Engl J Med
1990;322:1195-201.
6. Wajchenberg BL, Albergaria Pereira MA,
Mendonça BB, Latronico AC, Campos Carneiro
P, Alves VA, et al. Adrenocortical carcinoma:
clinical and laboratory observations. Cancer
2000;88:711-36.
7. Aiba M, Hirayama A, Iri H, Kodama T,
Fujimoto Y, Kusakabe K, et al. Primary
adrenocortical micronodular dysplasia: enzyme
histochemical and ultrastructural studies of two
cases with a review of the literature. Hum Pathol
1990;21:503-11.
8. Carney JA, Gordon H, Carpenter PC, Shenoy BV,
Go VL. The complex of myxomas, spotty
pigmentation, and endocrine overactivity. Medicine
(Baltimore) 1985;64:270-83.
9. Carney JA. Carney complex: the complex of
myxomas, spotty pigmentation, endocrine
overactivity and schwannomas. Semin Dermatol
1995;14:90-8.
10. Stratakis CA, Kirschner LS, Carney JA. Clinical
and molecular features of the Carney complex:
diagnostic criteria and recommendations for
patient evaluation. J Clin Endocrinol Metab
2001;86:4041-6.
11. Sandrini F, Stratakis C. Clinical and molecular
genetics of primary pigmented nodular
adrenocortical disease. Arq Bras Endocrinol
Metabol 2004;48:637-41.
12. Doppman JL, Chrousos GP, Papanicolaou DA,
Stratakis CA, Alexander HR, Nieman LK.
Adrenocorticotropin-independent macronodular
adrenal hyperplasia: an uncommon cause of
primary adrenal hypercortisolism. Radiology
2000;216: 797-802.
13.Shinojima H, Kakizaki H, Usuki T, Harabayashi
T, Ameda K, Koyanagi T Clinical and
endocrinological features of adrenocorticotropic
hormone-independent bilateral macronodular
adrenocortical hyperplasia. J Urol 2001;166:
1639-42.
14. Lacroix A, Ndiaye N, Tremblay J, Hamet P.
Ectopic and abnormal hormone receptors in
adrenal Cushing’s syndrome. Endocr Rev
2001;22:75-110.
15. Koch CA, Pacak K, Chrousos GP. The molecular
pathogenesis of hereditary and sporadic
adrenocortical and adrenomedullary tumors. J
Clin Endocrinol Metab 2002;87:5367-84.
16. Hingshaw HT, Ney RL. Abnormal control in the
neoplastic adrenal cortex. In: McKerns KW, ed.
13Síndrome de Cushing Independente do Hormônio Adrenocorticotrófico (ACTH)
Projeto Diretrizes
Associação Médica Brasileira e Conselho Federal de Medicina
Hormones and cancer. New York:Academic
Press;1974. p.309-27.
17. Antonini SR, Fragoso MC, Lacroix A.
Clinical and molecular aspects of the ACTH-
independent bilateral macronodular adrenal
hyperplasia. Arq Bras Endocrinol Metabol
2004;48:620-36.
18. Fragoso MC, Domenice S, Latronico AC,
Martin RM, Pereira MA, Zerbini MC, et
al. Cushing’s syndrome secondary to
a d r e n o c o r t i c o t r o p i n - i n d e p e n d e n t
macronodular adrenocortical hyperplasia
due to activating mutations of GNAS1
gene. J Clin Endocrinol Metab 2003,88:
2147-51.
19. Skogseid B, Rastad J, Gobl A, Larsson C,
Backlin K, Juhlin C, et al. Adrenal lesion in
multiple endocrine neoplasia type 1. Surgery
1995;118:1077-82.
20. Pannett AA, Thakker RV. Multiple endocrine
neoplasia type 1. Endocr Relat Cancer
1999;6: 449-73.
21. Findling JW, Doppman JL. Biochemical and
radiologic diagnosis of Cushing’s syndrome.
Endocrinol Metab Clin North Am 1994;23:
511-37.
22. Dickstein G, DeBold CR, Gaitan D,
DeCherney GS, Jackson RV, Sheldon WR
Jr, et al. Plasma corticotrophin and cortisol
responses to ovine corticotropin–releasing
hormone (CRH), arginine vasopressin (AVP),
CRH plus AVP, and CRH plus metyrapone
in patients with Cushing’s disease. J Clin
Endocrinol Metab 1996;81: 2934-41.
23. Vale W, Spiess J, Rivier C, River J. Characterization
of a 41-residue ovine hypothalamic peptide that
stimulates secretion of corticotropin and beta-
endorphin. Science 1981;213:1394-7.
24. Newell-Price J, Morris DG, Drake WM,
Korbonits M, Monson JP, Besser GM, et al.
Optimal response criteria for the human CRH
test in the differential diagnosis of ACTH-
dependent Cushing’s syndrome. J Clin
Endocrinol Metab 2002;87:1640-5.
25. Kaye TB, Crapo L. The Cushing´s syndrome:
an update on diagnostic tests. Ann Intern Med
1990;112:434-44.
26. Malerbi DA, Mendonça BB, Liberman B,
Toledo SP, Corradini MC, Cunha-Neto MB,
et al. The desmopressin stimulation test in the
differential diagnosis of Cushing’s syndrome.
Clin Endocrinol (Oxf) 1993;38: 463-72.
27. Findling JW, Doppman JL. Biochemical and
radiologic diagnosis of Cushing’s syndrome.
Endocrinol Metab Clin North Am 1994;23:
511-37.
28. Rockall AG, Babar SA, Sohaib SA, Isidori
AM, Diaz-Cano S, Monson JP, et al. CT and
MR imaging of the adrenal glands in ACTH-
independent Cushing syndrome. Radiographics
2004;24:435-52.
29. Mayo-Smith WW, Boland GW, Noto RB,
Lee MJ. State-of-the-art adrenal imaging.
Radiographics 2001;21:995-1012.
30. Miller JW, Crapo L. The medical treatment
of Cushing’s syndrome. Endocr Rev 1993;14:
443-58.